Journal: Journal of Neuroinflammation

Article Title: Activation of the nuclear receptor PPARδ is neuroprotective in a transgenic mouse model of Alzheimer’s disease through inhibition of inflammation

doi: 10.1186/s12974-014-0229-9

Figure Lengend Snippet: GW0742 treatment decreased the expression levels of proinflammatory mediators in the brains of 5XFAD mice. The expression levels of C3 (A) , C1qa (B) , IL-6 (C) ,TNFα (D) , CCL2 (E) , INFγ (F) , CXCR2 (G) and IL-1β (H) in the brain of the 5XFAD mice were analyzed by qPCR. Results are presented as mean ± SEM. VEH = vehicle- and GW0742 = GW0742-treated mice. ** P < 0.01 *** P < 0.001 as analyzed by 1-way ANOVA followed by Tukey’s post hoc test. n = 10 in WT vehicle-treated group, n = 9 in TG vehicle- and n = 9 in TG GW0742-treated group.

Article Snippet: The sections were incubated with antibodies to glial fibrillary acidic protein (GFAP; 1:500 dilution, Dako, Carpinteria, CA, USA), ionized calcium binding adaptor molecule 1 (Iba-1; 1:200 dilution, Wako Chemicals, Richmond, VA, USA), NeuN (Aves Labs Inc, Tigard, Oregon, USA), complement component 3 (C3) and C1qa (1:1,000 dilution, both from Novus Biologicals, Littleton, CO, USA,), and 6E10 (BioLegend, Dedham, MA, USA) followed by incubation with appropriate Alexafluor 488 or 546 conjugated secondary antibodies (Molecular Probes/Life Technologies, Grand Island, NY, USA).

Techniques: Expressing

Journal: Journal of Neuroinflammation

Article Title: Activation of the nuclear receptor PPARδ is neuroprotective in a transgenic mouse model of Alzheimer’s disease through inhibition of inflammation

doi: 10.1186/s12974-014-0229-9

Figure Lengend Snippet: The expression levels of C1qa and C3 were reduced in GW0742-treated mouse brain as analyzed by immunohistochemistry. Immunohistochemistry against C1qa and C3 revealed a staining pattern associated predominantly with glial fibrillary acidic protein (GFAP) immunoreactivity. Figures (A) and (B) show typical example images of C1qa and GFAP immunoreactivities in vehicle-treated TG mice, respectively and figure (C) is the overlay of C1qa and GFAP. Figures (D-F) show example images of corresponding immunoreactivities in GW0742-treated TG mice. Figures (G-H) show C3 and GFAP immunoreactivities in vehicle-treated TG mice and figure (I) the overlay of C3 and GFAP. Figure (J-L) depict example images of corresponding immunoreactivities in GW0742-treated TG mice. The high magnification insets show typical C1qa and C3 staining pattern resembling astrocytes. Scale bar = 200 μm.

Article Snippet: The sections were incubated with antibodies to glial fibrillary acidic protein (GFAP; 1:500 dilution, Dako, Carpinteria, CA, USA), ionized calcium binding adaptor molecule 1 (Iba-1; 1:200 dilution, Wako Chemicals, Richmond, VA, USA), NeuN (Aves Labs Inc, Tigard, Oregon, USA), complement component 3 (C3) and C1qa (1:1,000 dilution, both from Novus Biologicals, Littleton, CO, USA,), and 6E10 (BioLegend, Dedham, MA, USA) followed by incubation with appropriate Alexafluor 488 or 546 conjugated secondary antibodies (Molecular Probes/Life Technologies, Grand Island, NY, USA).

Techniques: Expressing, Immunohistochemistry, Staining

Journal: Diabetology & Metabolic Syndrome

Article Title: Single-cell RNA sequencing reveals roles of unique retinal microglia types in early diabetic retinopathy

doi: 10.1186/s13098-024-01282-3

Figure Lengend Snippet: Inflammatory and activation characteristics of microglial subtypes. A Three-dimensional UMAP plot of microglia and macrophages. The different colors correspond to different cell types. B Boxplot showing the marker genes of microglia and macrophages. According to their different gene expression profiles, the microglia were categorized into three groups: Egr2 + M1 microglia ( C1qa + , Ccr5 + , Egr2 + ), Egr2 − M1 microglia ( C1qa + , Ccr5 + , Egr2 − ) and M2 microglia ( C1qa + , Ccr5 − , Egr2 − ). Macrophages highly expressed Cxcr4 . C Immunofluorescence labeling for C1qa (red) and Ccr5 (green) and DAPI nuclear staining (blue) in the rat retina. M1 microglia are indicated by arrows, and M2 microglia are indicated by arrowheads (above, 63 ×). Immunofluorescence labeling for Ccr5 (red) and Egr2 (green) and DAPI nuclear staining (blue) in the rat retina. Egr2 + M1 microglia are indicated by arrows, and Egr2 − M1 microglia are indicated by arrowheads (below, 63 ×). Scale bar 20 µm. D Immunofluorescence labeling for C1qa (red) and Ccr5 (green) and DAPI nuclear staining (blue). M2 microglia are indicated by arrows (left, 20 ×). Immunofluorescence labeling for Ccr5 (red) and Egr2 (green) and DAPI nuclear staining (blue). Egr2 + M1 microglia are indicated by arrowheads, and Egr2 − M1 microglia are indicated by asterisks (right, 20 ×). Scale bar 50 µm. E Plot showing the pathways enriched in M2 microglia in GSEA. The threshold limits were a p value < 0.1 and a FDR q-value < 0.25. F Heatmap showing the average expression of inflammatory mediators in microglia and macrophages. The plot is ordered by the three gene categories (labels on left). High expression is in red, and low expression is in blue. G Bubble plots showing the expression of inflammatory cytokines in microglia subpopulations from different data sets. The size of each circle is proportional to the percentage of gene expression. High expression is shown in blue, and low expression is shown in gray. Mouse_2, Mouse_3 and Mouse_brain were obtained from normal mouse samples. H Bubble plot showing the expression of inflammatory mediators in Egr2 + M1 microglia and Egr2 − M1 microglia in different stages of DR. The size of each circle is proportional to the percentage of gene expression. High expression is shown in red/yellow, and low expression is shown in gray

Article Snippet: Antibodies used in this study were as follows: Purified mouse Complement Component C1qA Antibody (NOVUS NBP1-51,139); Rabbit Monoclonal EGR2 Antibody (JG78-39); Rat monoclonal [HEK/1/85a] to CCR5 (Abcam ab11464); Cy3–conjugated Affinipure Goat Anti-Mouse IgG(H + L) (SA00009-1); Goat Anti-Rabbit IgG(H + L), Mouse/Human ads-APC (SBA-4050-11S).

Techniques: Activation Assay, Marker, Gene Expression, Immunofluorescence, Labeling, Staining, Expressing

Journal: Diabetology & Metabolic Syndrome

Article Title: Single-cell RNA sequencing reveals roles of unique retinal microglia types in early diabetic retinopathy

doi: 10.1186/s13098-024-01282-3

Figure Lengend Snippet: Activation mechanism of microglia. A Volcano plot showing the DEGs between Egr2 + M1 microglia and Egr2 − M1 microglia. The adjusted P value and gene expression (log fold change) were used for the plot. B PPI network showing the highly expressed proteins of Egr2 + M1 microglia. The size and color represent the combined score of each protein. Significant proteins are marked with red circles. C Heatmap showing the enrichment of pathways in different subtypes of microglia in GSVA. High expression is in red, and low expression is in blue. D Violin plot showing the expression of inflammatory receptors in the three groups of microglia. E Gating strategy for sorting Egr2 + M1 cells. Egr2 + M1 cells are gated as Ccr5 + C1qa + Egr2 + cells. F The bar graph shows the qPCR results for Egr2 + M1 cells. * denotes a p-value of < 0.05, ** denotes a p-value of < 0.01 and *** denotes a p-value of < 0.001. The levels of inflammatory cytokines like Tnf and members of the AP-1 family were significantly elevated in Egr2 + M1 cells compared to normal cells

Article Snippet: Antibodies used in this study were as follows: Purified mouse Complement Component C1qA Antibody (NOVUS NBP1-51,139); Rabbit Monoclonal EGR2 Antibody (JG78-39); Rat monoclonal [HEK/1/85a] to CCR5 (Abcam ab11464); Cy3–conjugated Affinipure Goat Anti-Mouse IgG(H + L) (SA00009-1); Goat Anti-Rabbit IgG(H + L), Mouse/Human ads-APC (SBA-4050-11S).

Techniques: Activation Assay, Gene Expression, Expressing